Instil Bio TIL
NASDAQ TIL
$6.31 -0.04 (-0.63%)
At close: Nov 11, 2026 · 4:00 PM EST

Instil Bio (TIL) EBITDA Margin (2020)

Updated

Instil Bio's EBITDA Margin came in at -24194.20% for FY2020.

Analysis

Instil Bio (TIL) EBITDA Margin (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 32.68%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 46.88%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 40.60%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 39.77%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 46.62%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 50.63%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 42.49%
10 Instil Bio 43.07 Mn -256.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -14,700.00%
Jun 30, 2020 -10,854.76%
Mar 31, 2020 -8,763.64%
API Access

Instil Bio EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TIL&period=max&api_key=YOUR_API_KEY